Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2026-01-08 @ 8:30 PM
Study NCT ID:
NCT03878433
Status:
COMPLETED
Last Update Posted:
2021-09-14
First Post:
2019-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral Superoxide Dismutase (GLISODin) to Decrease Melasma Severity.
Sponsor:
Centre Hospitalier Universitaire de Nice
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melasma | View |
Keywords: